Published in Gene Therapy Weekly, February 10th, 2005
According to a study from the Peoples Republic of China, "somatostatin receptor subtypes, especially subtype 2 (SSTR2), exert antitumor (cytostatic and/or cytotoxic) and antiangiogenic effects. Here we aimed to investigate the antiangiogenic effect of SSTR2 gene transfer into pancreatic cancer cell line PC-3, and the mechanisms involved in this effect."
"The full-length human SSTR2 complementary DNA was introduced into pancreatic cancer cell line PC-3 by lipofectamine-mediated transfection, and stable expression of SSTR2 was detected by immunohistochemistry and reverse...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.